Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 146
Selected: 0
NCT IDTitle
NCT07428655Acceptability and Feasibility of PSC Model of Serious Illness Communication
NCT04451603LiverMultiScan Analysis of MRI Scans in HCC
NCT02801734Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer
NCT02808091Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma
NCT05581550Somatostatin Receptor Imaging in NPC, EBV Related Cancers
NCT04242251Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT03267641Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
NCT01394315Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer
NCT01736410A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
NCT00801411Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
NCT03212807Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
NCT06093061Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
NCT06418412A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
NCT04104113Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT07626814Increasing Uptake of Cascade Testing in Families With Familial Cancer Syndromes: A Randomized Controlled Trial of a Registry-aided Model.
NCT02736305Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
NCT01309607Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
NCT00003637Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
NCT02435927ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
NCT06044441Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
NCT04738708Telegenetics or In-Person Genetic Counselling
NCT03670342Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer
NCT04946968Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
NCT03330509Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital
NCT05377034Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT07234357Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
NCT05059340Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM
NCT00589186Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
NCT01022723Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
NCT04664829The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT03100006Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT05286437Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT07241715Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT00997906Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
NCT02559336Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital
NCT00263484Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
NCT04632173Head and Neck cancERs International cOviD-19 collabOraTion
NCT03093831Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
NCT00687648Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT05957068Breast Cancer Exercise Intervention Study
NCT03325218Survival Expectations and Hope Among Cancer Patients at End-of-Life
NCT02368860OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma
NCT07111130Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
NCT01865838A Study Into the Effect of Seprafilm in Open Total Thyroidectomy
NCT04961632Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376